Sunmax Biotechnology Co., Ltd. (TPEX: 4728)

Sunmax Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,164	854.69	589.3	602.55	778.58	583.49
Short-Term Investments	-	107.1	227.37	76.79	131.01	122.94
Trading Asset Securities	-	-	-	-	-	21.48
Cash & Short-Term Investments	1,164	961.79	816.67	679.34	909.59	727.91
Cash Growth	-0.58%	17.77%	20.22%	-25.31%	24.96%	38.31%
Accounts Receivable	1.64	2.55	1.94	3.72	7.63	21.17
Other Receivables	10.26	6.84	1.37	4.71	2.88	17.22
Receivables	11.9	9.39	3.3	8.43	10.51	38.39
Inventory	133.25	93.67	73.79	54.74	25.33	41.2
Other Current Assets	47.19	14.08	11.81	45.06	20.09	18.22
Total Current Assets	1,356	1,079	905.58	787.57	965.53	825.71
Property, Plant & Equipment	978.02	904.32	604.39	485.56	277.18	138.65
Long-Term Investments	-	-	10.3	17.18	7.48	32.88
Other Intangible Assets	4.31	5.06	3.84	3.84	5.18	8.74
Long-Term Deferred Tax Assets	36.07	53.39	20.76	17.32	11.82	11.62
Other Long-Term Assets	19.95	117.33	248.41	172.55	96.93	95.05
Total Assets	2,395	2,159	1,793	1,484	1,364	1,113
Accounts Payable	13.74	11.98	21.77	14.95	7.18	9.88
Current Portion of Leases	23.26	24.24	13.27	32.28	24.69	7.16
Current Income Taxes Payable	97.53	89.03	82.94	70.84	29.13	32.68
Current Unearned Revenue	104.12	202.57	60.09	122.95	111.56	158.34
Other Current Liabilities	724.05	129.62	147.93	92.93	121.95	67.56
Total Current Liabilities	962.7	457.43	326	333.95	294.51	275.62
Long-Term Leases	137.31	144.78	49.82	66.9	105.27	109.82
Long-Term Deferred Tax Liabilities	76.61	105.19	57.16	22.16	39.4	12.87
Other Long-Term Liabilities	26.36	25.59	35.02	37.43	36.09	34.96
Total Liabilities	1,203	732.99	468	460.44	475.27	435.82
Common Stock	544.63	544.63	544.63	544.63	544.63	544.63
Additional Paid-In Capital	3.65	3.65	3.65	25.44	25.44	25.44
Retained Earnings	652.47	891.19	771.66	460.46	323.74	115.14
Comprensive Income & Other	-9.13	-13.42	5.33	-6.95	-4.97	-8.37
Total Common Equity	1,192	1,426	1,325	1,024	888.84	676.83
Shareholders' Equity	1,192	1,426	1,325	1,024	888.84	676.83
Total Liabilities & Equity	2,395	2,159	1,793	1,484	1,364	1,113
Total Debt	160.57	169.02	63.09	99.18	129.96	116.98
Net Cash (Debt)	1,003	792.78	753.58	580.16	779.64	610.94
Net Cash Growth	0.50%	5.20%	29.89%	-25.59%	27.61%	21.63%
Net Cash Per Share	18.40	14.54	13.82	10.64	14.30	11.20
Filing Date Shares Outstanding	54.46	54.46	54.46	54.46	54.46	54.46
Total Common Shares Outstanding	54.46	54.46	54.46	54.46	54.46	54.46
Working Capital	393.54	621.51	579.57	453.62	671.02	550.09
Book Value Per Share	21.88	26.18	24.33	18.79	16.32	12.43
Tangible Book Value	1,187	1,421	1,321	1,020	883.66	668.09
Tangible Book Value Per Share	21.80	26.09	24.26	18.72	16.22	12.27
Land	64.9	-	-	-	-	-
Buildings	505.55	487.13	482.71	-	-	-
Machinery	338.88	293.4	82.42	62.95	98.43	82.2
Construction In Progress	7.88	17.79	-	331.26	86.92	9.75
Leasehold Improvements	45.14	44.01	44.79	44.4	44.82	5.4

Source: S&P Capital IQ. Standard template. Financial Sources.